Switch to
More onapp

How to use scorecard? Learn more

Venus Remedies Ltd

VENUSREM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹401 cr, stock is ranked 1,831
High RiskStock is 5.49x as volatile as Nifty
301.451.40 (+0.47%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

Avg

Can be considered moderately valued vs the market

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹401 cr, stock is ranked 1,831
High RiskStock is 5.49x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
13.82
PB RatioPB Ratio
0.87
Dividend YieldDiv. Yield
Sector PESector PE
43.93
Sector PBSector PB
6.03
Sector Div YldSctr Div Yld
0.58%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Venus Remedies Limited is engaged in pharmaceutical product manufacturing business. The Company provides formulations and manufactures dosage injectables.

Financial TrendFinancial statements 

2020202120222023375.99600.36608.49565.83-10.0061.7640.7426.58
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Trading Window-XBRL 
Announced OnApr 1, 2024

Venus Remedies Limited has informed the Exchange about Closure of Trading Window | Download

Venus Remedies Limited has informed the Exchange about Closure of Trading Window | Download

Loss/Duplicate-Share Certificate-XBRL 
Announced OnMar 29, 2024

VENUS REMEDIES LIMITED has informed the Exchange about Loss of share certificates | Download

VENUS REMEDIES LIMITED has informed the Exchange about Loss of share certificates | Download

Cash Dividend 
Ex. DateSep 23, 2013

Final • Div/Share: ₹ 3

See all events